SUMO2 Antibody - BSA Free

Small ubiquitin-like modifiers (SUMOs) are a family of small, related proteins (Sumo-1/2/3/4) that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation, which is a major regulator of protein function in cellular processes such as nuclear transport, transcriptional regulation, apoptosis and protein stability. All SUMO proteins localize to the nucleus and are covalently conjugated, affecting protein structure, function and interactions. SUMO2 and 3 are 96% identical and are more mobile within nucleus relative to SUMO1. Specific functional differences between SUMO1 and SUMO2 and 3 remain to be identified.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 2 applications: ICC/IF, IP.

Showing Publications 1 - 2 of 2.

Publications using NBP1-77163	Applications	Species
Xu H, Akinyemi IA, Haley J et al. ATM, KAP1 and the Epstein-Barr virus polymerase processivity factor direct traffic at the intersection of transcription and replication Nucleic acids research 2023-10-19 [PMID: 37852757] (IP, Human)	IP	Human
Volcic M, Sparrer KMJ, Koepke L et al. Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1 Nat Microbiol 2020-07-20 [PMID: 32690953] (ICC/IF, Human)	ICC/IF	Human

Array NBP1-77163

• SUMO2 Antibodies
• SUMO2 ELISA Kit
• SUMO2 Lysates
• SUMO2 Proteins